EVALUATION OF A NOVEL, NATURAL LOCUST BEAN GUM AS A SUSTAINED RELEASE AND MUCOADHESIVE COMPONENT OF TIZANIDINE HYDROCHLORIDE BUCCAL TABLETS

Authors

  • HARIKRISHNAN V ASSISTANT PROFESSORNATIONAL COLLEGE OF PHARMACYMANASSERY CALICUT
  • MADHUSUDHAN S M.Pharm,PhD
  • SANTHIAGU A Doctor of Philosophy (Ph. D) in Biochemical Engineering (2006) - School of Biochemical Engineering Institute of Technology Banaras Hindu University, Varanasi

Abstract

Mucoadhesive polymers that bind to the gastric mucins or epithelial cell surface are useful in drug delivery for the purpose of increasing the intimacy andduration of contact of the drug with the absorbing membrane. Mainly synthetic polymers are in use for this purpose. Probably the biodegradability of thesynthetic polymers is questionable. In the present work mucoadhesive buccal tablets of tizanidine hydrochloride were prepared using locust bean gumthat has better mucoadhesive property than synthetic polymer. The in vitro adhesive and mucoadhesive strength and swelling property of mucoadhesivmaterial locust bean gum were evaluated by Share Stress and Park and Robinson methods. Buccal formulations of tizanidine hydrochloride tablets werprepared using locust bean gum, and thickness, hardness, friability, weight variation, and assay of tablets were tested. The in vitro drug release studof tizanidine hydrochloride exhibited extended drug release profile for tablets prepared. Higuchi and Peppas data reveal that the drug released by nonFickian
diffusion mechanism. The present
study
shows
that formulation
containing 50% locust bean gum have
greater
mucoadhesive
property
than allother
formulation.
Increase
in concentration
of locust bean gum increases
in the bioadhesive
strength
and swelling
ratio
in the 50
mg
of locust bean gum.
Keywords: Mucoadhesive, Tizanidine hydrochloride, Tablets, Locust bean gum.

Downloads

Download data is not yet available.

References

Nance PW, Bugaresti J, Shellenberger K, Sheremata W, Martinez-

Arizala A. Efficacy and safety of tizanidine in the treatment of spasticity

in patients with spinal cord injury. North American Tizanidine Study

Group. Neurology 1994;44 11 Suppl 9:S44-51.

Wagstaff AJ, Bryson HM. Tizanidine. A review of its pharmacology,

clinical efficacy and tolerability in the management of spasticity

associated with cerebral and spinal disorders. Drugs 1997;53(3):435-52.

Moffat AC. Clark’s Isolation and Identification of Drugs. London:

Pharmaceutical Press; 2006. p. 691.

Mumtaz AM, Ching HS. Design of a dissolution apparatus suitable

for in situ release study of triamcinolone acetonide from bioadhesive

buccal tablets. Int J Pharm 1995;121:129-39.

Bottenberg P, Cleymaet R, de Muynck C, Remon JP, Coomans D,

Michotte Y, et al. Development and testing of bioadhesive, fluoridecontaining

slow-release

tablets

for oral use. J

Pharm

Pharmacol

;43(7):457-64.

Cafaggi S, Leardi R, Parodi B, Caviglioli G, Russo E, Bignardi G.

Preparation and evaluation of a chitosan salt-poloxamer 407 based

matrix for buccal drug delivery. J Control Release 2005;102(1):159-69.

Duchene D, Touchard F, Peppas NA. Pharmaceutical and medical

aspects of bioadhesive systems for drug administration. Drug Dev Ind

Pharm 1988;14:283.

El-Samaligy MS, Yahia SA, Basalious EB. Formulation and

evaluation of diclofenac sodium buccoadhesive discs. Int J Pharm

;286(1-2):27-39.

Mohammed FA, Khede H. Preparation and in vitro/in vivo evaluation

of the buccal bioadhesive propertis of slow - Release tablets containing

Miconazole Nitrate. Drug Dev Ind Pharm 2003;29:321-37.

Finn A, Collins J, Voyksner R, Lindley C. Bioavailability and

metabolism of prochlorperazine administered via the buccal and oral

delivery route. J Clin Pharmacol 2005;45(12):1383-90.

Nakhat PD, Kondawar AA, Babla IB, Rathi LG, Yeole PG. Studies

on buccoadhesive tablets of terbutaline sulphate. Indian J Pharm Sci

;69(4):505-10.

Park K, Robinson JR. Bioadhesive polymers as platforms for oral –

Controlled drug delivery: Method to study bioadhesion. Int J Pharm

;19:107-27.

Costa P, Sousa Lobo JM. Modeling and comparison of dissolution

profiles. Eur J Pharm Sci 2001;13(2):123-33.

Peppas NA, Korsmeyer RW. Hydrogels in Medicine and Pharmacy:

Properties and Application. Vol. 1. Boca Raton: CRC; 1986. p. 103-9.

Pramod Kumar TM, Shivakumar SG. Novel core in cup buccoadhesive

systems and films of terbutaline sulphate – Development and in vitro

evaluation. AJPS 2006;1:175-87.

Chanda R, Mahapatro SK, Roy A, Bahadur S. Development of oral

mucoadhesive tablets of terbutaline sulphate using some natural

materials extracted from Albelmoschus esculeatus and Tamarindus

indica. Res J Pharm Technol 2008;11:46-52.

Save T, Shah MU, Ghamande AR, Venkitachalam P. Comparative study

of buccoadhesive formulation and sublingual capsule of nifedipine.

J Pharm Pharmacol 1994;46:192-5.

Chen WG, Chi Hwang GC. Adhesive and in vitro release characteristics

of propranolol bioadhesive disc system. Int J Pharm 1992;82:61-6.

Yamazaki N, Monma Y, Tanabe T. Effect of propranolol and atenolol on

rat kidney. Nippon Yakurigaku Zasshi 1983;81(5):33-9.

Vijayaraghavan C, Vasanthakumar S, Ramakrishnan K. An in vitro and

in vivo evaluation of locust bean gum and chitosan combination as a

carrier for buccal drug delivery. Pharmazie 2008;63(5):112-4.

Degim T, Eglen B, Ocak O. A sustained release dosage form of

acyclovir for buccal application: An experimental study in dogs. J Drug

Target 2006;14(1):35-44.

Published

01-11-2015

How to Cite

V, H., M. S, and S. A. “EVALUATION OF A NOVEL, NATURAL LOCUST BEAN GUM AS A SUSTAINED RELEASE AND MUCOADHESIVE COMPONENT OF TIZANIDINE HYDROCHLORIDE BUCCAL TABLETS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 8, no. 6, Nov. 2015, pp. 7-10, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/7731.

Issue

Section

Review Article(s)